Literature DB >> 17324967

Intrarenal cytokine gene expression in lupus nephritis.

Rebecca Wing-Yan Chan1, Fernand Mac-Moune Lai, Edmund Kwok-Ming Li, Lai-Shan Tam, Kai-Ming Chow, Ka-Bik Lai, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

BACKGROUND: Lupus nephritis is characterised by intrarenal inflammation and lymphocyte activation. AIM: To examine the profile of cytokine gene expression in glomerulus and tubulointerstitium in patients with lupus nephritis.
METHODS: 36 consecutive patients with systemic lupus erythematosus having active renal disease were recruited, and they were required to undergo kidney biopsy. Glomerular and tubulointestitial cytokine expression of interleukin (IL)2, 4, 10, 12, 18, interferon gamma (IFN)gamma, T-bet (the Th1 transcription factor), GATA-3 (the Th2 transcription factor), transforming growth factor beta and monocyte chemoattractant protein (MCP)1 were studied by laser microdissection of the renal biopsy specimen, followed by real-time quantitative PCR.
RESULTS: There were 13 patients with World Health Organization class III nephritis, 14 patients with class IV nephritis and 9 patients with class V nephritis. There was a significant correlation between serum C3, C4 and anti-double strand DNA antibody level with glomerular expression of T-bet, IFNgamma and IL2. There was a significant correlation between histological activity index and glomerular expression of IL12, IL18, IL10 and MCP1. In addition, the degree of glomerular leucocyte infiltration significantly correlated with glomerular expression of IFNgamma, IL10, IL12 and IL18. By contrast, histological chronicity index correlated with the tubulointerstitial expression of IL2, MCP1 and GATA-3.
CONCLUSIONS: Intraglomerular expression of certain target genes correlate with the severity of systemic as well as histological activity, whereas the tubulointerstitial expression of other target genes correlate with the degree of chronic kidney scarring. This result may shed light on the immunopathogenesis of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324967      PMCID: PMC1955122          DOI: 10.1136/ard.2006.063123

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

2.  The GATA-3 gene is expressed during human kidney embryogenesis.

Authors:  M C Labastie; M Catala; J M Gregoire; B Peault
Journal:  Kidney Int       Date:  1995-06       Impact factor: 10.612

Review 3.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Cytokine balance in kidney tissue from lupus nephritis patients.

Authors:  W-S Uhm; K Na; G-W Song; S-S Jung; T Lee; M-H Park; D-H Yoo
Journal:  Rheumatology (Oxford)       Date:  2003-03-31       Impact factor: 7.580

5.  Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.

Authors:  Karin S Peterson; Jing-Feng Huang; Jessica Zhu; Vivette D'Agati; Xuejun Liu; Nancy Miller; Mark G Erlander; Michael R Jackson; Robert J Winchester
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Teresa Yuk-Hwa Wong; Carol Yi-Ki Szeto; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Arthritis Rheum       Date:  2004-09

7.  Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Lai-Shan Tam; Edmund Kwok-Ming Li; Fernand Mac-Moune Lai; Kai-Ming Chow; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Arthritis Rheum       Date:  2003-05

8.  Interleukin-4 expression in mesangial proliferative glomerulonephritis.

Authors:  H Okada; K Konishi; Y Nakazato; Y Kanno; H Suzuki; H Sakaguchi; T Saruta
Journal:  Am J Kidney Dis       Date:  1994-02       Impact factor: 8.860

9.  Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

Authors:  S Takahashi; L Fossati; M Iwamoto; R Merino; R Motta; T Kobayakawa; S Izui
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  Prognostic factors in lupus nephritis. Contribution of renal histologic data.

Authors:  H A Austin; L R Muenz; K M Joyce; T A Antonovych; M E Kullick; J H Klippel; J L Decker; J E Balow
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

View more
  26 in total

1.  Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis.

Authors:  Yan-bin Zhou; Ren-gao Ye; You-ji Li; Can-mao Xie
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

2.  Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus.

Authors:  Gang Wang; Lai-Shan Tam; Bonnie Ching-Ha Kwan; Edmund Kwok-Ming Li; Kai-Ming Chow; Cathy Choi-Wan Luk; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Clin Rheumatol       Date:  2011-10-07       Impact factor: 2.980

Review 3.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

4.  Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.

Authors:  Stephen D Marks; Vanita Shah; Clarissa Pilkington; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

5.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

6.  Epigenetics in systemic lupus erythematosus.

Authors:  Gong Xiao; Xiaoxia Zuo
Journal:  Biomed Rep       Date:  2015-12-11

7.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Facilitated expansion of Th17 cells in lupus nephritis patients.

Authors:  B Jakiela; J Kosałka; H Plutecka; S Bazan-Socha; M Sanak; J Musiał
Journal:  Clin Exp Immunol       Date:  2018-09-23       Impact factor: 4.330

9.  Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis.

Authors:  Y Wang; S Ito; Y Chino; D Goto; I Matsumoto; H Murata; A Tsutsumi; T Hayashi; K Uchida; J Usui; K Yamagata; T Sumida
Journal:  Clin Exp Immunol       Date:  2009-10-06       Impact factor: 4.330

Review 10.  Urine biomarkers in juvenile-onset SLE nephritis.

Authors:  Louise Watson; Michael W Beresford
Journal:  Pediatr Nephrol       Date:  2012-05-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.